Trials / Completed
CompletedNCT04672382
Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine
Effect of Intradermal Morphine Application on Histaminergic and Non-histaminergic Itch and Related TRPV1 and Antihistamine Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Aalborg University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to the effect of opioid (morphine) intradermal application on histaminergic and non-histaminergic itch. In particular, we would like to demonstrate that also peripheral administration of morphine may affect mast cell release of histamine.
Detailed description
Opioids (i.e. substances extracted from opium poppies, e.g. morphine) are used for treatment of both acute and chronic pain conditions as well as in surgical procedures. Opioids render effective pain relief, however, they may cause bothersome itch as a side effect. With this series of experiments, we wish to clarify how an injection with morphine in the skin layer called dermis (located right below the upper skin) will affect itch.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine | During the 1st session, each of the middle forearms of the subject will be divided into two squared areas (4x4 cm) located 3 cm apart. Two areas will be treated with an intradermal injection of morphine (0.05 ml, 0.1 mg/ml), and two areas with an intradermal injection of isotonic saline. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-05-31
- Completion
- 2022-12-31
- First posted
- 2020-12-17
- Last updated
- 2023-01-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04672382. Inclusion in this directory is not an endorsement.